PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection
Boyi Liao(Ministry of Education of the People's Republic of China), Jian Zhou(Shenzhen University Health Science Center), Xin Zhang(Sichuan Cancer Hospital), Zheng Wang(Nankai University), Jia Fan(Nanjing Tech University), Weifeng Liu(Fudan University), Lei Yu(Taiyuan Central Hospital), Zao‐Zhuo Shen(Fudan University), Jie Hu(Zhongshan Hospital)
Cited by 31
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644